The Renal Denervation Buzz: Separating Fact From Myth

Is renal denervation the next blockbuster device technology? Judging by the excitement at the EuroPCR meeting in May, the potential is there. Just before the meeting, Covidien announced its acquisition of renal denervation start-up Maya Medical.

More from Archive

More from Medtech Insight